Q1 2021 Getinge AB Earnings Call Transcript
Hello, and welcome to the Getinge AB Q1 Report 2021. (Operator Instructions) Just to remind you, this conference call is being recorded.
Today, I'm pleased to present Mattias Perjos, CEO. Please begin with your meeting.
Thank you very much, and welcome to today's conference, everyone. I have Lars Sandström, our CFO, with me, and he will present the financials a little bit later on.
But let's move directly over to Page #2, please. So we'll start with a bit of a summary from a financial perspective of the first quarter. So these are the key takeaways. We had organic net sales growth of 12.6% for the first quarter of this year. This is mainly explained by large deliveries of products for Sterile Transfer and ECMO therapy, where we expect continued strong demand going forward as well. We also delivered a large number of advanced ICU ventilators in the quarters, but expect sales events to return to more normal levels for the full year of 2021. So we confirm what we've said earlier in that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |